Cell Therapy: Regulatory & Supply Chain Insights for Human AB Serum

Presented by Rob Perry from GeminiBio and Troy Fugate from Compliance Insight

Rob Perry, CSO at GeminiBio, brings over 20 years of cell therapy manufacturing expertise in facility design, technology transfer and regulatory compliance. He has served as Senior Director at Atara Biotherapeutics and Co-founder & VP of Manufacturing & Logistics at Athersys, overseeing life-sciences builds exceeding $50 million.

Troy Fugate, VP at Compliance Insight, Inc., has led a team of industry professionals and former FDA inspectors for over 23 years, excelling in regulatory compliance and efficiently resolving FDA issues.

Register for our latest webinar

GeminiBio, in collaboration with Compliance Insight, Inc., a nationally recognized compliance firm serving FDA-regulated industries, is hosting a webinar on human serum use in cell therapy development and manufacturing. Register now and gain expert insight into regulatory considerations impacting human serum use in cell therapies, as well as supply chain challenges and strategies to ensure continuity.

Discover how, as a cell therapy developer, you can de-risk development and accelerate timelines.

Fill out the form to register the webinar.